Data4Cure @ PMWC 2018: Combining systems biology, machine learning and tumor evolution to improve biomarkers for IO

A key challenge in the field of immunotherapy is predicting which patients will respond to IO therapy either as a single agent or in combination with other treatments. Clinical and experimental strategies involve testing expression of individual markers or gene panels, assessing tumor mutation burden and MSI status, and more recently, approaches examining specific tumor…
Read more